In the 15th and final chapter of its series on Johnson & Johnson’s Risperdal (risperidone), the Huffington Post (10/2) “Highline” recounts how the jury in the Pledger case handed down its verdict Feb. 24, 2015, finding J&J was negligent by failing to provide an adequate warning about the risk of […]
J&J
2 posts
By Kim Truongle – AMS – Our firm is part of a multi-firm settlement with AMS. If you are one of our AMS clients and have not yet been contacted by us, your contact information may be outdated, so please contact us at (800) 269-3050. Settlement administration is expected to […]